Welcome to The Future Labs, a podcast series talking to people building the future, today. We speak to thought leaders around the globe about the ideas and technologies that will shape our future.

In this episode, we are exploring The Future of Voice Biomarkers (and maybe coining the term "voice-omics"!) and the potential to diagnose medical conditions based on voice. We are speaking to Ed Kliphuis, Investment Director at M Ventures, the corporate venture capital arm of Merck KGaA. Ed spoke with us about their recent investment into Sonde Health, a digital medicine company developing diagnostic tools based on voice biomarkers.

Music: Beauty From Nothing by David Ibbett, performed by Sophia Subbayya Vastek